Position in JAZZ
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$25,286,186
-$1,842,299 QoQ
Shares Held
104,935
-26.9% QoQ
Ownership
0.162%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#83
of 629 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 27%
Shared 0%
None 73%
Common Shares in JAZZ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PANAGORA ASSET MANAGEMENT INC holds $624,607,308 across 78 Biotechnology names. JAZZ ranks #6 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
175,291 | $109,300,950 | |
| 2 | INCY |
Incyte Corp
|
881,889 | $99,970,937 | |
| 3 | XENE |
Xenon Pharmaceuticals Inc.
|
664,031 | $40,080,911 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
337,461 | $39,506,559 | |
| 5 | TVTX |
Travere Therapeutics, Inc.
|
490,724 | $27,878,030 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
This page
|
104,935 | $25,286,186 | |
| 7 | RLAY |
Relay Therapeutics, Inc.
|
1,291,182 | $24,158,015 | |
| 8 | CLDX |
Celldex Therapeutics, Inc.
|
572,538 | $21,304,138 |
All Filings in JAZZ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,286,186 | 104,935 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $27,128,485 | 143,499 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $15,946,340 | 93,802 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $201,785 | 1,531 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $9,252,496 | 87,189 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $10,837,425 | 87,293 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $223,147 | 1,812 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $200,760 | 1,802 | Shares | Sole | 2024-11-13 | |
| 2024-03-31 | $1,909,861 | 15,860 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $2,221,134 | 18,058 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,637,545 | 12,651 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $1,451,936 | 11,712 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $15,624,239 | 106,774 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,300,288 | 8,162 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $944,626 | 7,087 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $969,758 | 6,216 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $973,404 | 6,253 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,174,882 | 9,222 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $21,274,230 | 163,384 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $34,959,552 | 196,800 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $22,395,905 | 136,253 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $13,379,613 | 81,064 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,298,550 | 16,120 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,739,951 | 15,769 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $1,385,089 | 13,887 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||